Industry-Wide Tariffs Loom Over the Healthcare Sector. Here Are 2 Stocks That Can Weather the Storm.

In its Q2 earnings call Thursday, Novartis said it is moving quickly to reshore its drug manufacturing operations, but CEO ...

Novartis ( NYSE: NVS) CEO Vas Narasimhan said the company has built up its U.S. inventories to help mitigate the impact of ...

Johnson & Johnson halved its expectations for costs this year related to new tariffs and raised its full-year sales and ...

Australia is evaluating the impact of potential US tariffs of 200% on pharmaceutical imports, Treasurer Jim Chalmers said, while reiterating that his nation’s subsidies for certain drugs are not up ...

Some GOP lawmakers and pro-trade lobbyists are quietly seeking to rein in the most extreme elements of the Trump ...

President Donald Trump’s threat to slap 30 percent tariffs on the European Union starting Aug. 1 derailed weeks of delicate negotiations and risks upending what E.U. officials call the most important ...

President Donald Trump's proposed tariffs on pharmaceuticals could lead to higher prices, higher insurance premiums, and even drug shortages, experts say.

American consumers of Korean cosmetics and skin-care products are bulk buying, as President Trump threatens 25 percent ...

J&J (NYSE:JNJ) stock surges rallying peers despite Trump's latest tariff threats on pharma as the company posts a quarterly ...

President Trump said he was likely to impose tariffs on pharmaceuticals as soon as the end of the month, starting with a "low ...

The opening salvo of second-quarter earnings calls this week came against President Donald Trump’s renewed calls for a tariff ...